China Resources Sanjiu Medical & Pharmaceutical (SHE:000999) is collaborating with affiliate CR Power (HKG:0836) to integrate traditional Chinese medicine cultivation with renewable energy projects.
Under the agreement, CR Sanjiu will provide land remediation services, including planting medicinal herbs, for CR Power's solar farms, according to a Thursday filing with the Shenzhen bourse.
Annual transactions are capped at 200 million yuan, totaling up to 600 million yuan from 2025 to 2027.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.